• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by Advent Technologies Holdings Inc.

    5/14/25 1:14:26 PM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ADN alert in real time by email
    NT 10-Q 1 adventtechnologies_nt10q.htm NT 10-Q

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 12b-25

     

     

     

    NOTIFICATION OF LATE FILING

     

    SEC File Number: 001-38742

    CUSIP Number: 00165R101

     

    (Check one):      

    ☐  Form 10-K     ☐  Form 20-F     ☐  Form 11-K   ☒   Form 10-Q

    ☐  Form 10-D     ☐  Form N-CEN     ☐  Form N-CSR

       
        For Period Ended: March 31, 2025
       
        ☐ Transition Report on Form 10-K
       
        ☐ Transition Report on Form 20-F
       
        ☐ Transition Report on Form 11-K
       
        ☐ Transition Report on Form 10-Q
       
        For the Transition Period Ended: _______________

     

    Read Instructions (on back page) Before Preparing Form. Please Print or Type.

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

     

     

    PART I—REGISTRANT INFORMATION

     

    Advent Technologies Holdings, Inc.

    Full Name of Registrant

     

    AMCI Acquisition Corp.

    Former Name if Applicable

     

    5637 La Ribera St., Suite A

    Address of Principal Executive Office (Street and Number)

     

    Livermore, CA 94550

    City, State and Zip Code

     

     

     

     

    PART II—RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

    ☒ (a)

    The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

         
    ☐ (b)

    The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

         
    ☐ (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III—NARRATIVE

     

    State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period. (Attach extra Sheets if Needed)

     

    Advent Technologies Holdings, Inc. (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the period ended March 31, 2025 (the “Quarterly Report”) by the prescribed due date. The Company requires additional time to complete the final review of its financial statements and other disclosures in the Quarterly Report.

     

    The Company is working diligently to complete the Quarterly Report as quickly as possible.

     

    PART IV—OTHER INFORMATION

     

    (1) Name and telephone number of person to contact in regard to this notification
           
      Gary Herman   925   455-9400
      (Name)   (Area Code)   (Telephone Number)
       
    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes  ☐    No  ☒
       
      The Company is working to complete its Annual Report on Form 10-K for the period ended December 31, 2024, as disclosed by the Company in that certain Notification of Late Filing on Form 12b-25 filed with the U.S. Securities and Exchange Commission on March 31, 2025.
       
       
    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes  ☐    No  ☒
       
     

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

    2

     

     

    Advent Technologies Holdings Inc.

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: 

    May 14, 2025

      By: 

    /s/ Gary Herman

           

    Gary Herman

    Chief Executive Officer

     

    3

    Get the next $ADN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ADN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ADN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Advent Technologies Announces Joseph Hosni as Director of Commercial Sales

      ATHENS, Greece and LIVERMORE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent "or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology sector, is pleased to announce that Joseph Hosni has joined the Company as the Director of Commercial Sales. Mr. Hosni will be based at the Company's Athens office. Mr. Hosni has over 25 years of experience in advancing technology and infrastructure sales. Prior to joining Advent, he most recently was the Commercial Director of VEN Engineering. Mr. Hosni stated, "I am excited to work closely with the new management team at Advent to execute on the vision of Advent 2.0." Kons

      5/27/25 10:00:00 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies Receives Nasdaq Notice on Late Filing of its Form 10-Q

      LIVERMORE, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:ADN) On May 22, 2025, Advent Technologies Holdings, Inc. (the "Company") received a letter (the "Letter") from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") notifying the Company that it is not in compliance with periodic requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) because the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2025 was not filed with the Securities and Exchange Commission by the required due date of May 15, 2025, and because the Company's Annual Report on Form 10-K for the year ended December 31, 2024 was not filed by the required

      5/23/25 7:00:00 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies Announces Dr. Ryan Pavlicek as General Manger of Livermore Facility

      LIVERMORE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent "or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology sector, is pleased to announce that Dr. Ryan Pavlicek has rejoined the Company as the General Manager of its Livermore facility. Dr. Pavlicek previously served as a Senior Scientist, Product Manager, and Site Lead with Advent from 2018-2024. Prior to this, Dr. Pavlicek served as a Technology Manager with the Hydrogen and Fuel Cell Technologies Office at the U.S. Department of Energy. Dr. Pavlicek has more than 10 years experience developing and scaling fuel cell technologies, and was a key me

      5/12/25 9:00:00 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous

    $ADN
    SEC Filings

    See more
    • SEC Form 10-Q filed by Advent Technologies Holdings Inc.

      10-Q - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Filer)

      6/30/25 5:15:21 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form 10-K filed by Advent Technologies Holdings Inc.

      10-K - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Filer)

      6/6/25 1:16:30 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form NT 10-Q filed by Advent Technologies Holdings Inc.

      NT 10-Q - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Filer)

      5/14/25 1:14:26 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous